Prediabetes

References

Citations

1. Swinburn BA, et al. (2001). Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care, 24(4): 619–624.

2. American Diabetes Association (2004). Frequently asked questions about pre-diabetes. Available online: http://www.diabetes.org/pre-diabetes/faq.jsp.

3. American Diabetes Association (2000). Type 2 diabetes in children and adolescents. Pediatrics, 105(3): 671–680.

4. American Diabetes Association (2004). Screening for type 2 diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S11–S14.

5. Capes S, Anand S (2001). What is type 2 diabetes? In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 151–163. Hamilton, ON: BC Decker.

6. Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6): 393–403.

7. U.S. Department of Health and Human Services (2008). 2008 Physical Activity Guidelines for Americans (ODPHP Publication No. U0036). Washington, DC: U.S. Government Printing Office. Available online: http://www.health.gov/paguidelines/pdf/paguide.pdf.

8. American Diabetes Association (2004). Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care, 27(Suppl 1): 134–140.

9. American Diabetes Association (2008). Standards of medical care in diabetes. Diabetes Care, 31(Suppl 1): S12–S54.

10. U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.

11. American Diabetes Association (2004). Prevention or delay of type 2 diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S47–S50.

12. Uusitupa M, et al. (2003). Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish diabetes prevention study. Diabetes, 52(10): 2532–2538.

13. Van Dam RM, et al. (2002). Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Annals of Internal Medicine, 136(3): 201–209.

14. Lindstrom J, et al. (2003). The Finnish diabetes prevention study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 26(12): 3230–3236.

15. American Diabetes Association (2004). Smoking and diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S74–S75.

16. Lindstrom J, et al. (2003). Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish diabetes prevention study: Results from a randomized trial. Journal of the American Society of Nephrology, 14(7, Suppl 2): S108–S113.

17. Tuomilehto J, et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344(18): 1343–1350.

18. Gerstein HC, et al. (2006). Effects of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial. Lancet, 368(9541): 1096–1105.

Other Works Consulted

• Liao D, et al. (2002). Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. Diabetes Care, 25(9): 1504–1510.

• Mirza SA (2007). Metabolic disorders. In RE Rakel, ET Bope, eds., Conn's Current Therapy, pp. 675–682. Philadelphia: Saunders Elsevier.

• National Diabetes Education Program (2006). Small steps, big rewards: Your game plan for preventing type 2 diabetes. Available online: http://ndep.nih.gov.

• Norris SL, et al. (2005). Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database of Systematic Reviews. Oxford: Update Software.

• Rao SS, et al. (2004). Impaired glucose tolerance and impaired fasting glucose. American Family Physician, 69(8): 1961–1968.

• Riddle MC, Genuth S (2007). Type 2 diabetes mellitus. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 2. New York: WebMD.

Go to previous section	Go to top of page	Go to next section
Author:	Caroline Rea, RN, BS, MS	Last Updated: August 12, 2008
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Jennifer Hone, MD - Endocrinology, Diabetes and Metabolism
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.